Navigation Links
PAREXEL Strengthens Late Phase and Observational Research Capabilities With Expert Team to Help Biopharma Meet Commercialization Goals
Date:11/23/2011

BOSTON, Nov. 23, 2011 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has appointed several executives to its global team of late phase and observational research experts in PAREXEL's PACE™ (Peri-Approval Clinical Excellence) group. This team will help sponsors collect the precise data they need to prove the value of their products to multiple stakeholders, and better position their products for commercial success.

"Observational research has become increasingly important as a means to demonstrate product value in a real world clinical setting," said Carol Collins, Ph.D., Corporate Vice President and Worldwide Head of PACE at PAREXEL.

"These appointments to the PAREXEL PACE global team of late phase experts add extensive expertise to help clients optimize the design and execution of their late phase and observational research programs to seamlessly move products from clinical development through commercialization."

The experts newly appointed to PAREXEL's PACE group include:

  • Peggy Schrammel, Vice President and Global Head Portfolio Management, PACE:  Ms. Schrammel's professional experience includes senior-level positions at major clinical research organizations (CROs), where she designed and managed late phase programs including patient registries, clinical-experience trials, pharmacoeconomic trials, and managed-care-based effectiveness trials. Ms. Schrammel received an undergraduate degree in political science and Master of Public Administration from the University of Pittsburgh.
  • Neal Mantick, Senior Director, Global Observational Research'/>"/>

  • SOURCE PAREXEL International Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
    2. UCB and PAREXEL Sign Strategic Partnership Agreement
    3. PAREXEL International to Present at Lazard Capital Markets Healthcare Conference and Citi Small/Mid Cap Conference
    4. PAREXEL Commercialization Experts to Present Best-Practice Approaches for Demonstrating Product Value at ISPOR Annual European Congress
    5. PAREXEL Reports First Quarter Fiscal Year 2012 Financial Results
    6. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
    7. New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership
    8. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
    9. PAREXEL Announces Date of First Quarter Fiscal Year 2012 Earnings Release and Conference Call
    10. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
    11. PAREXEL International Reports Fourth Quarter and Fiscal Year 2011 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/28/2015)... 2015  Rosa & Co. LLC, a drug development ... today announced its pleasure to be lead partner for ... Systems Pharmacology (QSP). The conference focuses on uses and ... Logo - ... Rosa,s lead sponsorship is the second of ...
    (Date:4/28/2015)... , April 28, 2015  BioDelivery Sciences International, ... Sarah DeRossett , MD, PhD to the position ... Affairs.  Dr. DeRossett joins BDSI with nearly twenty-five ... the neurosciences area.  Dr. DeRossett will oversee clinical ... well as the medical support for BDSI,s currently ...
    (Date:4/27/2015)... China , April 27, 2015 Techpool Bio-Pharma ... under the leadership of its new chief executive officer, transforming ... Before Henry Lee took office in ... in the pharmaceutical field, including Novartis and Eisai, with more ... China and the Asia-Pacific ...
    Breaking Medicine Technology:Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 3BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 2BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 3BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 4Techpool Transforms Into International Player 2Techpool Transforms Into International Player 3
    ... Aug. 2 Cytokine PharmaSciences,Inc. (CPSI) today ... inhibitors showed oral efficacy in animal models. ... it is advancing one of these compounds,into ... or MIF, is linked to many,conditions, including ...
    ... ARBOR, Mich., Aug. 3 Far more of today,s,heart attack ... clogged heart arteries than even a,decade ago, a new study ... from this urgent treatment,-- which is known to save lives ... it at all, the study shows. And the chance ...
    Cached Medicine Technology:Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors 2Many Heart Attack Patients Don't Get Best Emergency Treatment 2Many Heart Attack Patients Don't Get Best Emergency Treatment 3Many Heart Attack Patients Don't Get Best Emergency Treatment 4
    (Date:4/28/2015)... China (PRWEB) April 28, 2015 Georgia ... major municipalities in China that will partner with the ... reduce smoking in a nation that produces more tobacco ... world. , The project, China Tobacco Control Partnership-Tobacco Free ... leaders have shown willingness to support tobacco control efforts ...
    (Date:4/28/2015)... Missouri (PRWEB) April 28, 2015 ... to healthcare executive search, announced today that it has ... & Chief Operating Officer search for The ... , Reporting to QHS President & CEO Arthur ... Officer will have operating responsibility for the Queen’s Medical ...
    (Date:4/28/2015)... April 28, 2015 Georgia Partnership ... establishment of telemedicine programs in communities throughout Georgia, announces ... selected as speakers at the American Telemedicine Association ... 2015, in Los Angeles, CA. , GPT’s roster ... Sherrie Williams, Executive Director; Loren Nix, Liaison; and board ...
    (Date:4/28/2015)... April 28, 2015 Researchers from four ... dose of a steroid prior to pemetrexed (Alimta) chemotherapy ... reaction. Click here to read the full story ... from the Raabe College of Pharmacy in Ohio, Stanford ... Appalachian Regional Healthcare in Kentucky gave a single dose ...
    (Date:4/28/2015)... (PRWEB) April 28, 2015 Dead or damaged ... and their property. In many cases, tree removal by a ... way to eliminate the threat. , In their ... of tree removal available to property owners today. Each method ... for a job well done. , The article states that, ...
    Breaking Medicine News(10 mins):Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:Georgia Partnership for TeleHealth Team Selected to Present at ATA 2015 2Health News:Study Finds New Regimen May Ward Off Skin Rash from Common Mesothelioma Drug, According to Surviving Mesothelioma 2Health News:Tree Removal Methods and Services Discussed in Recent Article by Precision Tree Services 2
    ... Crestor worked well in those with normal LDL but ... 9 (HealthDay News) -- A widely used cholesterol-lowering drug ... adverse outcomes in people who do not ... Crestor (rosuvastatin), did have high levels of C-reactive protein ...
    ... LAFAYETTE HILL, Pa., Nov. 9 The NHS Human,Services ... on November,8, 2008 at the Hyatt Regency Penn,s Landing ... for the Foundation, which supports the mission,of NHS Human ... human,services in the country., Every year the Foundation ...
    ... time to change their Medicare Part D Prescription Drug Coverage begins November ... they so choose, this time period is also an opportunity for people ... , ... Washington (PRWEB) November 9, 2008 -- The National Council on Aging ...
    ... Glaucoma-related highlights of today,s scientific program of the 2008 ... and European Society of Ophthalmology (SOE) include a study ... carotid artery narrowing and potentially elevated risk for stroke, ... of fasting, common to the world,s seven major religions, ...
    ... a risk factor for high blood pressure, low levels ... as high levels of sodiumespecially among African Americans, according ... Nephrology,s 41st Annual Meeting and Scientific Exposition in Philadelphia, ... about lowering salt or sodium in the diet in ...
    ... patients in need of organ transplants on the rise, ... sources for organs. Individuals are willing to donate their ... the poverty rate is high, resulting in numerous reports ... troubling issue will be the topic of a session ...
    Cached Medicine News:Health News:Statin Might Help More People Fight Heart Disease Than Thought 2Health News:Statin Might Help More People Fight Heart Disease Than Thought 3Health News:Gala Raises Funds for NHS Human Services 2Health News:Attention Seniors: Plans Change. Your Needs Change. Shop and Compare Your Prescription Drug Coverage Now 2Health News:Attention Seniors: Plans Change. Your Needs Change. Shop and Compare Your Prescription Drug Coverage Now 3Health News:Attention Seniors: Plans Change. Your Needs Change. Shop and Compare Your Prescription Drug Coverage Now 4Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 2Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 3Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 4Health News:Low potassium linked to high blood pressure 2Health News:Transplant experts convene at ASN Renal Week 2008 to discuss organ trafficking 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: